ArticleArchives of virology2025
Detection of Leishmania RNA virus 2 in clinical isolates of Leishmania from Qom Province, Iran.
Article in Archives of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Leishmaniasis, which is caused by protozoan parasites belonging to the genus Leishmania remains a public-health concern across the provinces of Iran, necessitating better treatments and control strategies. Leishmania RNA virus (LRV) primarily infects Leishmania major and is known to influence disease severity and drug resistance. In this study, we investigated the presence of LRV2 (LRV type 2 in the Old World) in Leishmania isolates from patients with cutaneous leishmaniasis in Qom, Iran, in 2019–2020. Samples from 15 patients were analyzed for species identification using ITS1-PCR-RFLP and for LRV2 detection using RT-PCR, semi-nested PCR, and Sanger sequencing. The viral load was quantified by qRT-PCR. Of the 15 L. major isolates, nine (60%) carried LRV2. Phylogenetic analysis revealed a close relationship to strains previously reported in Golestan province. Given the large number of travelers in Qom, the detection of LRV2 underscores the need for ongoing surveillance and further research into its role in leishmaniasis transmission, clinical outcomes, and drug resistance.
Indexed as
Identifiers
41139333What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.